APTALIS PHARMA INC Operating Cash Flow
APTALIS PHARMA INC reported Operating Cash Flow of $13.24 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-02-10
- APTALIS PHARMA INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $13.24M, a 258.12% increase year-over-year.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was $14.56M.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for the quarter ending 2010-12-31 was $3.70M.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for the quarter ending 2010-09-30 was -$2.54M.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for fiscal 2011 was -$49.01M, a 177.65% decline from fiscal 2010.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for fiscal 2010 was $63.12M, a 31.68% decline from fiscal 2009.
- APTALIS PHARMA INC net cash provided by (used in) operating activities for fiscal 2009 was $92.38M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2011-12-31 | $13.24M 10-Q · filed 2012-02-10 | $27.80M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2011-09-30 | $14.56M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$49.01M 10-K · filed 2011-12-20 | ||
| 2011-06-30 | -$63.58M 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $3.70M 10-Q · filed 2012-02-10 | $1.16M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $63.12M 10-K · filed 2011-12-20 | ||
| 2010-06-30 | $65.66M 10-Q · filed 2011-08-12 | |||
| 2009-09-30 | $92.38M 10-K · filed 2011-12-20 |